-
Product Insights
NewChronic Lymphocytic Leukemia (CLL) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Chronic Lymphocytic Leukemia (CLL) Clinical Trial Report Overview A total of 2311 CLL clinical trials were conducted as of April 2024. The CLL clinical trial report provides a comprehensive understanding of the CLL clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions · North America · Europe...
-
Product Insights
NewEpilepsy Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Epilepsy Clinical Trial Report Overview A total of 3474 epilepsy clinical trials were conducted as of April 2024. The epilepsy clinical trial report provides a comprehensive understanding of the epilepsy clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions · North America · Europe · Asia-Pacific · ...
-
Sector Analysis
NewElectrophysiology Lab Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Electrophysiology Lab Systems Market Report Overview The electrophysiology lab systems market size is $661.8 million in 2023. The market is expected to grow at a CAGR of more than 4% during 2023 and 2033. Electrophysiology Lab Systems are used for the visualization, diagnosis, and treatment of cardiac arrhythmias. Electrophysiology Lab Systems Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Electrophysiology Lab Systems Market Forecast Download A Free Report Sample The electrophysiology lab systems market...
-
Thematic Analysis
NewPsychedelics Therapeutics Development and Trends, 2024
This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. The report identifies the broader changes within the evolving psychedelic industry, facilitating informed decision-making for relevant sectors.
-
Sector Analysis
NewRetinitis Pigmentosa (RP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Retinitis Pigmentosa (RP) Marketed and Pipeline Drugs Report Overview Retinitis pigmentosa (RP) is a cluster of rare eye conditions. One of these conditions causes degeneration of the retina, the light-sensitive layer at the back of the eye. This degeneration results in a progressive loss of vision. Retinitis pigmentosa is an inherited genetic disorder. Most people have progressive vision loss over time, with symptoms usually starting in childhood. While there isn't a cure at this time, people can maximize their residual...
-
Product Insights
NewLeft Atrial Appendage Closure Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Left Atrial Appendage Closure Devices Pipeline Market Report Overview Left atrial appendage closure device prevents blood flow into the left atrial appendage, preventing blood clotting or pooling. It consists of left atrial appendage implanted occlusion devices and left atrial appendage ligation devices. One unit refers to one left atrial appendage closure device. The left atrial appendage closure devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development....
-
Sector Analysis
NewSouth Africa Remote Patient Monitoring Devices Market Summary, Competitive Analysis and Forecast to 2028
Remote Patient Monitoring Devices in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Remote patient monitoring (RPM) involves the utilization of digital technologies and services to oversee, analyze, and capture patients' health data, which is subsequently transmitted to healthcare professionals for thorough...
-
Sector Analysis
NewMiddle East and Africa (MEA) Remote Patient Monitoring Devices Market Summary, Competitive Analysis and Forecast to 2028
Remote Patient Monitoring Devices in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 19-3., and forecast to 28). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Remote patient monitoring (RPM) involves the utilization of digital technologies and services to oversee, analyze, and capture patients' health data, which is subsequently transmitted to healthcare professionals for thorough...
-
Sector Analysis
NewCell and Gene Therapies in Ophthalmology – Disease Overview, Treatment Options and Future Market Assessment
Cell and Gene Therapies in Ophthalmology Market Report Overview The Cell and Gene Therapies (CGT) in ophthalmology market was $46 million in 2023. The market will experience moderate growth during the forecast period with gene therapies targeting Leber congenital amaurosis (LCA) and retinitis likely to be the primary drivers of the CGT market in the ophthalmology space. The CGT in ophthalmology market research report will aid clients in gaining insight into the competitive landscape of leading CGT agents in ophthalmology...
-
Innovation Ranking
NewInnovation Ranking – Johnson Matthey Plc
Johnson Matthey Plc (Johnson Matthey) is a speciality chemicals and sustainable technologies provider. It offers catalysts and related technologies for automotive, pharmaceuticals and chemical processing. It also undertakes the marketing, distribution, fabrication, refining and recycling of precious metals and their products. It also develops and manufactures active pharmaceutical ingredients. The company provides battery materials for automotive applications; battery systems for a range of applications and fuel cell technologies. It serves environmental, automotive, chemical, medical, recycling, oil and gas and other...